The literature points to a 16-fold increased risk of PTC or FTC in individuals with DICER1 mutations but also suggests the syndrome’s contribution to familial multinodular goiters and thyroid carcinomas is small [5,17]. This evidence concerns the gene DICER1 and thyroid cancer, nonmedullary, 2.